245 related articles for article (PubMed ID: 2849551)
1. Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells.
Rincón M; Tugores A; López-Rivas A; Silva A; Alonso M; De Landázuri MO; López-Botet M
Eur J Immunol; 1988 Nov; 18(11):1791-6. PubMed ID: 2849551
[TBL] [Abstract][Full Text] [Related]
2. Delineation of the mechanism of inhibition of human T cell activation by PGE2.
Minakuchi R; Wacholtz MC; Davis LS; Lipsky PE
J Immunol; 1990 Oct; 145(8):2616-25. PubMed ID: 1976699
[TBL] [Abstract][Full Text] [Related]
3. Activation of the CD3/T cell receptor (TcR) complex or of protein kinase C potentiate adenylyl cyclase stimulation in a tumoral T cell line: involvement of two distinct intracellular pathways.
Bihoreau C; Heurtier A; Enjalbert A; Corvaïa N; Bensussan A; Degos L; Kordon C
Eur J Immunol; 1991 Nov; 21(11):2877-82. PubMed ID: 1657616
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels.
Anastassiou ED; Paliogianni F; Balow JP; Yamada H; Boumpas DT
J Immunol; 1992 May; 148(9):2845-52. PubMed ID: 1374102
[TBL] [Abstract][Full Text] [Related]
5. Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5.
Vandenberghe P; Ceuppens JL
Eur J Immunol; 1991 Feb; 21(2):251-9. PubMed ID: 1705509
[TBL] [Abstract][Full Text] [Related]
6. Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor in activated human T lymphocytes.
Borger P; Kauffman HF; Vijgen JL; Postma DS; Vellenga E
Exp Hematol; 1996 Feb; 24(2):108-15. PubMed ID: 8641331
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
Chouaib S; Welte K; Mertelsmann R; Dupont B
J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of murine T cell activation by cholera toxin B subunit is not mediated through the phosphatidylinositol second messenger system.
Woogen SD; Turo K; Dieleman LA; Beagley KW; Elson CO
J Immunol; 1993 Apr; 150(8 Pt 1):3274-83. PubMed ID: 8468469
[TBL] [Abstract][Full Text] [Related]
9. PGE2 induces IL-1beta gene expression in mouse osteoblasts through a cAMP-PKA signaling pathway.
Park YG; Kang SK; Noh SH; Park KK; Chang YC; Lee YC; Kim CH
Int Immunopharmacol; 2004 Jun; 4(6):779-89. PubMed ID: 15135319
[TBL] [Abstract][Full Text] [Related]
10. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
[TBL] [Abstract][Full Text] [Related]
11. IFN-gamma and prostaglandin E2 inhibit IL-4-induced expression of Fc epsilon R2/CD23 on B lymphocytes through different mechanisms without altering binding of IL-4 to its receptor.
Galizzi JP; Cabrillat H; Rousset F; Ménétrier C; de Vries JE; Banchereau J
J Immunol; 1988 Sep; 141(6):1982-8. PubMed ID: 2844892
[TBL] [Abstract][Full Text] [Related]
12. Elevation of 3'5' cyclic adenosine monophosphate alters CD3 and CD25 antigens expression in activated T lymphocytes.
Iwaz J; Lafont S; Cordier G; Revillard JP
J Clin Lab Immunol; 1989 Jun; 29(2):85-9. PubMed ID: 2561159
[TBL] [Abstract][Full Text] [Related]
13. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
Bjorndahl JM; Sung SS; Hansen JA; Fu SM
Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432
[TBL] [Abstract][Full Text] [Related]
14. Cholera toxin inhibits resting human T cell activation via a cAMP-independent pathway.
Anderson DL; Tsoukas CD
J Immunol; 1989 Dec; 143(11):3647-52. PubMed ID: 2555413
[TBL] [Abstract][Full Text] [Related]
15. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
Tao X; Davis LS; Hashimoto K; Lipsky PE
J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP-mediated alteration of the CD2 activation process in human T lymphocytes. Preferential inhibition of the phosphoinositide cycle-related transduction pathway.
Bismuth G; Theodorou I; Gouy H; Le Gouvello S; Bernard A; Debré P
Eur J Immunol; 1988 Sep; 18(9):1351-7. PubMed ID: 2901964
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP- and inositol phosphate-independent inhibition of Ca2+ influx by cholera toxin in CD3-stimulated Jurkat T cells. A study with a cholera toxin-resistant cell variant and the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin.
Gouy H; Cefai D; Christensen SB; Debre P; Bismuth G
J Immunol; 1991 Aug; 147(3):757-66. PubMed ID: 1650386
[TBL] [Abstract][Full Text] [Related]
18. Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression.
Ledbetter JA; Parsons M; Martin PJ; Hansen JA; Rabinovitch PS; June CH
J Immunol; 1986 Nov; 137(10):3299-305. PubMed ID: 3021852
[TBL] [Abstract][Full Text] [Related]
19. Costimulation of cAMP and protein kinase C pathways inhibits the CD3-dependent T cell activation and leads to a persistent expression of the AP-1 transcription factor.
Rincón M; Tugores A; de Landázuri MO; López-Botet M
Cell Immunol; 1993 Jul; 149(2):343-56. PubMed ID: 8392437
[TBL] [Abstract][Full Text] [Related]
20. EP4/EP2 receptor-specific prostaglandin E2 regulation of interleukin-6 generation by human HSB.2 early T cells.
Zeng L; An S; Goetzl EJ
J Pharmacol Exp Ther; 1998 Sep; 286(3):1420-6. PubMed ID: 9732406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
